Cancer Treatment Today

Interferon is known to have anti-prliferative effects against pancreatic cancer cells, especially in the  IRF-2  pathway. Unfortunately, clinical support has been delayed. Most available studies had been in adjuvant settings where the drug's anti-angiogenic properties may be most prominent. A few metastatic studies do not demonstrate a marked benefit of adding interferon to chemotherapy.   NeoPlas Innovation’s Stephen Cantrell, M.D., has

The antigen leukocyte cellular antibody test (ALCAT) is a proprietary test created and promoted by American Medical Testing Laboratories and  Cell Science Systems, of Deerfield Beach, Florida. They market the procedure as an in-vitro screening test for adverse reactions to specific foods, food additives, food colourings and other chemicals. The test has been reformulates several times. IT is generally considered to be an unproven test(1).  "These